DJIA 18,135.72 38.82 0.21%
NASDAQ 4,982.81 15.67 0.32%
S&P 500 2,101.04 2.51 0.12%
market minute promo

6.82 -0.21 (-2.99%)

REAL-TIME: Last trade at

Extended Hours: $6.82 $0.00 (-0.01%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

PGNX $6.82 -2.99%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.03
Previous Close $7.03
Daily Range $6.80 - $7.25
52-Week Range $3.10 - $7.84
Market Cap $474.4M
P/E Ratio 63.91
Dividend (Yield) $0.00 (0.0%)
Volume 775,655
Average Daily Volume 695,099
Current FY EPS $0.02

Sector

Healthcare

Industry

Drug Makers

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary Rss Feed

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Actavis' Q4 Earnings to Beat Expectations, Growth Continues - Analyst Blog

Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog

Actavis' Appeal Case for Namenda Gets Accelerated Hearing - Analyst Blog

KaloBios Pharmaceuticals' KB001-A Fails Primary Endpoint - Analyst Blog

The Biggest Risks For Stocks In 2015?

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, Sells Tableau Software, ...

Progenics Pharmaceutical (PGNX) Upgraded From Sell to Hold

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall Street

Progenics Pharmaceuticals' (PGNX) CEO Mark Baker Q3 2014 Results - Earnings Call Transcript

See More PGNX News...

PGNX's Top Competitors

PGNX $6.82 (-2.99%)
Current stock: PGNX
AMGN $159.60 (0.26%)
Current stock: AMGN
GILD $103.42 (0.34%)
Current stock: GILD
BIIB $425.61 (2.77%)
Current stock: BIIB